# 7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori

> **NCT07352098** · NA · NOT_YET_RECRUITING · sponsor: **Yueyue Li** · enrollment: 290 (estimated)

## Conditions studied

- Helicobacter

## Interventions

- **DRUG:** 7-day high-dose vonoprazan-amoxicillin dual therapy group
- **DRUG:** 14-day vonoprazan-amoxicillin dual therapy group

## Key facts

- **NCT ID:** NCT07352098
- **Lead sponsor:** Yueyue Li
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352098, "7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07352098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*